Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon

Completed · Not applicable

Conditions studied: CRC Screening

In brief

This study was design to establish the effectiveness of PillCam® Platform with the PillCam® COLON 2 capsule as demonstrated by the identification of subjects with polyps as compared to optical colonoscopy.

Key facts

Study ID: NCT01372878
Run by: Medtronic - MITG
People needed: 884
Starts: 2011-06-01
Expected to finish: 2012-06-01
Last updated by the study team: 2019-08-01

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subject is between 50 - 75 years of age, and is classified as average risk per the AGA Guidelines on CRC Screening.
Subject received an explanation about the nature of the study and agrees to provide written informed consent.

You may not qualify if…

Subject has a history of colorectal cancer
Subjects with history of any positive colon assessment (including CT, optical colonoscopy, sigmoidoscopy etc.)
Subject with history of negative colon assessment (including CT, optical colonoscopy, sigmoidoscopy etc.) < 5 years as these subjects would be defined not requiring screening in this time frame
Subject has a first degree relative diagnosed with colorectal cancer before the age of 60 years old or 2 (or more) first degree relatives diagnosed with colorectal cancer at any age.
Subject is suspected or diagnosed with familial adenomatous polyposis, hereditary non polyposis colon cancer, or any high risk genetic syndrome.
Subject is suspected or diagnosed with inflammatory bowel disease, or chronic ulcerative colitis or Crohn's disease.
Subject is suspected or diagnosed with hematochezia, melena, Fe deficiency anemia or any other rectal bleeding, including positive FOBT test of any variety.
Subject is suspected or diagnosed with bowel obstruction.
Subject has dysphagia or any swallowing disorder.
Subject has congestive heart failure.
Subject has Type 1 or Type II Diabetes.
Subject has had prior abdominal surgery of the gastrointestinal tract in the last 6 months, other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator.
Subject has a cardiac pacemaker or other implanted electro medical device.
Subject has any allergy or other known contraindication to the medications used in the study.
Subject is expected to undergo MRI examination within 7 days after ingestion of the capsule.
Subject with any condition believed to have an increased risk for capsule retention such as intestinal tumors, radiation enteritis, and incomplete colonoscopies due to obstructions or NSAID enteropathy.
Subject with strictures, fistulas and/or chronic constipation.
Subject with history or clinical evidence of renal disease and/or previous clinically significant laboratory abnormalities of renal function parameters.
Subject with known gastrointestinal motility disorders.
Subject has known delayed gastric emptying.
Subject has any condition, which precludes compliance with study and/or device instructions.
Women who are either pregnant or nursing at the time of screening, or are of child-bearing potential and do not practice medically acceptable methods of contraception.
Subject suffers from life threatening conditions.
Concurrent participation in another clinical trial using any investigational drug or device.

Where it is running

Alabama Digestive Disorders Center P.C. — Huntsville, Alabama, United States
Indiana University Hospital — Indianapolis, Indiana, United States
Louisville Gastroenterology Associates — Louisville, Kentucky, United States
Specialists in Gastroenterology — St Louis, Missouri, United States
Research Associates of New York — New York, New York, United States
UNC Chapel Hill Gastroenterology and Hepatology — Chapel Hill, North Carolina, United States
Dayton Gstroenterology Inc. — Dayton, Ohio, United States
Franklin Gastroenterology, PLLC — Franklin, Tennessee, United States
Gastroenterology Consultants, P.A. — Houston, Texas, United States
Pasadena Gastroenterology Associates, P.A. — Pasadena, Texas, United States
Gastroenterology Associates of Tidewater — Chesapeake, Virginia, United States
Soroka University Medical Center — Beersheba, Israel
Rambam Medical Center — Haifa, Israel
Bikur Holim Hospital — Jerusalem, Israel
Rabin Medical Center — Petah Tikva, Israel
The Tel-Aviv Sourasky Medical Center — Tel Aviv, Israel
The Chaim Sheba Medical Center at Tel-Hashomer — Tel Litwinsky, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.